Morwak 250mgg, 500mg,750mg Tablets
PDF Leaflet Revision Date: 11 December 2019
Clinical Summary
Quick overview from the medicine insert
Indication
Short-term treatment of hyperemia and established coagulopathies.
Dosage (summary)
Adults: 1-1.5 g every 8 hours for 6-7 days; adjust for renal impairment.
Special Populations
- Renal impairment
Pregnancy & Breastfeeding
Safety not established; caution in lactating women as it passes into breast milk.
Key Drug Interactions
- Caution with other hemostatic agents
- Increased thrombus formation risk with estrogens
Contraindications
- Hypersensitivity to tranexamic acid
- History of thrombosis
- Severe renal impairment
Common side effects
- Nausea
- Vomiting
- Diarrhea
Counselling Points
- Take with plenty of fluids
- Monitor for signs of thrombosis
- Report any unusual bleeding
Serious warnings
- Not recommended in massive hematuria
- Risk of accumulation in renal insufficiency
Important Disclaimer
The Morwak 250mgg, 500mg,750mg Tablets professional information leaflet below is the property of Dr Reddy’S Laboratories and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
